BU researchers receive NIH grant to identify genetic factors for Alzheimer’s disease

The National Institutes of Health/National Institute on Aging recently awarded a $13.7 million grant to a project led by Boston University Chobanian & Avedisian School of Medicine principal investigators Lindsay Farrer, PhD, chief of biomedical genetics and distinguished professor of genetics, and Richard Sherva, PhD, assistant professor of medicine in biomedical genetics, for research using whole genome sequencing and other approaches to identify genetic factors for Alzheimer disease (AD) in Jews currently living in Israel who trace their ancestors to southern Spain and locations in the Middle East and North Africa (MENA) and Arab citizens of Israel.

Chatbots Crushed USMLE Step 3; Docs Use AI to Fight Insurers; AI for Nurses

Welcome to MedAI Roundup, highlighting the latest news and research in healthcare-related artificial intelligence each month. Former FDA Director Scott Gottlieb, MD, and colleagues pitted

July 26, 2024

Pharma companies to remain mum on CMS’ initial offers next week for the first year of IRA negotiations

One of the biggest (if not the single biggest) gripe that the pharma industry has with the Inflation Reduction Act is that it considers the

January 25, 2024

23andMe board rejects co-founder Anne Wojcicki’s offer to take company private

A special committee of the board of directors of 23andMe rejected an offer from the company’s co-founder and CEO, Anne Wojcicki, to take the company

August 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.